Interleukin 6 and haemostasis

scientific article

Interleukin 6 and haemostasis is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1046/J.1365-2141.2001.03061.X
P698PubMed publication ID11722403
P5875ResearchGate publication ID11634015

P2093author name stringStirling D
Ludlam CA
Kerr R
P2860cites workProduction of hybridoma growth factor by human monocytes.Q52827130
P433issue1
P407language of work or nameEnglishQ1860
P921main subjectinterleukinsQ194908
P304page(s)3-12
P577publication date2001-10-01
P1433published inBritish Journal of HaematologyQ4970200
P1476titleInterleukin 6 and haemostasis
P478volume115

Reverse relations

cites work (P2860)
Q44927461Active tuberculosis and venous thromboembolism: association according to international classification of diseases, ninth revision hospital discharge diagnosis codes
Q34002877Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells
Q44662101Age-related inflammatory cytokines and disease
Q35995696Ambient particulate matter accelerates coagulation via an IL-6-dependent pathway
Q34942534Associations between fibrin D-dimer, markers of inflammation, incident self-reported mobility limitation, and all-cause mortality in older men.
Q51139037Associations between vitamin K status and haemostatic and inflammatory biomarkers in community-dwelling adults. The Multi-Ethnic Study of Atherosclerosis.
Q46678880Associations of plasma pro-inflammatory cytokines, fibrinogen, viscosity and C-reactive protein with cardiovascular risk factors and social deprivation: the fourth Glasgow MONICA study
Q34335486Biomarkers and HIV-associated cardiovascular disease
Q38174213Biomarkers in atrial fibrillation: an overview
Q96618090COVID-19: review on latest available drugs and therapies against SARS-CoV-2. Coagulation and inflammation cross-talking
Q48560063Can haematological tests predict cardiovascular risk? The 2005 Kettle Lecture
Q43098741Changes in inflammatory biomarkers in patients treated with ticagrelor or clopidogrel
Q47927559Clear Cell Carcinoma of the Endometrium: Evaluation of Prognostic Parameters in a Multi-institutional Cohort of 165 Cases
Q36673531Coagulation interventions in experimental human endotoxemia
Q35926044Comparative aspects of blood coagulation
Q38669886Comparative assessment of immune complex-mediated hypersensitivity reactions with biotherapeutics in the non-human primate: Critical parameters, safety and lessons for future studies
Q40322916Crimean-Congo hemorrhagic fever virus activates endothelial cells
Q47201581D-dimer as a marker of acute pyelonephritis in infants younger than 24 months with urinary tract infection.
Q47903838Differential effects of mechanical ventilatory strategy on lung injury and systemic organ inflammation in mice
Q34662795Early inflammatory markers are independent predictors of cardiac allograft vasculopathy in heart-transplant recipients
Q84325750Effect of acute exacerbations on circulating endothelial, clotting and fibrinolytic markers in COPD patients
Q35597282Effect of intravenous N-acetylcysteine infusion on haemostatic parameters in healthy subjects
Q36331121Effects of febuxostat on platelet-derived microparticles and adiponectin in patients with hyperuricemia
Q37375244Effects of gender and dementia severity on Alzheimer's disease caregivers' sleep and biomarkers of coagulation and inflammation
Q34497358Effects of radiofrequency catheter ablation of atrial fibrillation on soluble P-selectin, von Willebrand factor and IL-6 in the peripheral and cardiac circulation
Q41131826Elevated Level of Circulating Platelet-derived Microparticles in Oral Cancer
Q53660624Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor.
Q51654721Elevated levels of tumor necrosis factor alpha and mortality in centenarians.
Q96960526Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study
Q46173252Exposure of mice to concentrated ambient particulate matter results in platelet and systemic cytokine activation
Q36154476Factor VIII in the setting of acute ischemic stroke among patients with suspected hypercoagulable state
Q37621119Fucoidan extracted from Fucus evanescens prevents endotoxin-induced damage in a mouse model of endotoxemia.
Q33399140Functional hyper-IL-6 from vaccinia virus-colonized tumors triggers platelet formation and helps to alleviate toxicity of mitomycin C enhanced virus therapy
Q48218551Growth Hormone (GH) and Cardiovascular System
Q37603069HHV-8-positive and EBV-positive intravascular lymphoma: an unusual presentation of extracavitary primary effusion lymphoma
Q47339155Haemostatic and inflammatory biomarkers in advanced chronic heart failure: role of oral anticoagulants and successful heart transplantation
Q44131690High sensitivity cardiac troponin T and interleukin-6 predict adverse cardiovascular events and mortality in anticoagulated patients with atrial fibrillation
Q41623499High-sensitivity C-reactive protein (hs-CRP) and tumor necrotizing factor-alpha (TNF-alpha) after on- and off- pump coronary artery bypass grafting
Q30514057In vivo imaging visualizes discoid platelet aggregations without endothelium disruption and implicates contribution of inflammatory cytokine and integrin signaling
Q24815899Incidence and risk factors of venous thromboembolism (VTD) in patients with amyloidosis
Q79215207Increased Levels of Hemostatic Proteins are Independent of Inflammation in Glycogen Storage Disease Type Ia
Q54049063Increased thrombin generation in a mouse model of cancer cachexia is partially interleukin-6 dependent.
Q52149539Inflammatory and metabolic markers and short-time outcome in patients with acute ischemic stroke in relation to TOAST subtypes.
Q42844870Inflammatory markers and exposure to occupational air pollutants
Q36283496Innate immunity and atherogenesis
Q57416312Inter-relationships of interleukin-6, cardiovascular risk factors and the metabolic syndrome among older men
Q35913178Interleukin-6 Is a Risk Factor for Atrial Fibrillation in Chronic Kidney Disease: Findings from the CRIC Study
Q37161467Interleukin-6 and JAK2/STAT3 signaling mediate the reversion of dexamethasone resistance after dexamethasone withdrawal in 7TD1 multiple myeloma cells
Q43148854Interleukin-6 receptor gene polymorphism modulates interleukin-6 levels and the metabolic syndrome: GBCS-CVD.
Q42905188Linking air pollution exposure with thrombosis
Q28755180Long-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic review
Q37096276Long-term variability of inflammatory markers and associated factors in a population-based cohort
Q35061559Markers of thrombogenesis and fibrinolysis and their relation to inflammation and endothelial activation in patients with idiopathic pulmonary arterial hypertension
Q99416910Massive pulmonary embolism following recovery from COVID-19 infection: inflammation, thrombosis and the role of extended thromboprophylaxis
Q42460075Modulation of plasma fibrinogen levels in acute-phase response after hepatectomy
Q41602019Monocytes regulate systemic coagulation and inflammation in abdominal sepsis
Q92572683Multiple plasma metals, genetic risk and serum C-reactive protein: A metal-metal and gene-metal interaction study
Q28728107On-versus Off-Pump Coronary Artery Bypass Grafting: No Difference in Early Postoperative Kidney Function Based on TNF-α or C-Reactive Protein
Q59798105Particulate Matter Air Pollution: Effects on the Cardiovascular System
Q27348345Particulate matter-induced lung inflammation increases systemic levels of PAI-1 and activates coagulation through distinct mechanisms
Q58093826Pathological effects of ionizing radiation: endothelial activation and dysfunction
Q36201980Physical activity and modulation of systemic low-level inflammation
Q92201372Plasma Levels of Vascular Endothelial Growth Factor and Selected Hemostatic Parameters in Association With Treatment Response in Multiple Myeloma
Q80347661Plasma levels of fibrinogen and C-reactive protein are related to interleukin-6 gene -572C>G polymorphism in subjects with and without hypertension
Q37142044Pleiotropic effects of thiazolidinediones
Q41177479Portal Venous Thrombosis-Disseminated Tuberculosis in Rheumatoid Arthritis
Q43004006Portopulmonary hypertension in cirrhosis: the pathogenetic challenge
Q35148377Post-stroke inflammatory response: effects of stroke evolution and outcome
Q44373643Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people
Q36902376Predictive value of circulating interleukin-6 and heart-type fatty acid binding protein for three months clinical outcome in acute cerebral infarction: multiple blood markers profiling study.
Q37059793Prognostic Impact of IL6 Genetic Variants in Patients with Metastatic Colorectal Cancer Treated with Bevacizumab-Based Chemotherapy
Q79322013Prognostic value of interleukin-6, plasma viscosity, fibrinogen, von Willebrand factor, tissue factor and vascular endothelial growth factor levels in congestive heart failure
Q37432302Promoter Polymorphism (-174, G/C) of Interleukin-6 and Arterial Thromboembolic Events: A Meta-Analysis
Q42667897Sex differences in the association between stressor-evoked interleukin-6 reactivity and C-reactive protein
Q49724056Significance of venous thromboembolism in women with uterine carcinosarcoma
Q36513378Signs of dysregulated fibrinolysis precede the development of type 2 diabetes mellitus in a population-based study
Q42750303Silencing of tissue factor by antisense deoxyoligonucleotide prevents monocrotaline/LPS renal injury in mice.
Q45857189Targeting factor VIII expression to platelets for hemophilia A gene therapy does not induce an apparent thrombotic risk in mice
Q107739555The Many Faces of JAKs and STATs Within the COVID-19 Storm
Q37017858The assessment of proinflammatory cytokines in the patients with the history of cerebral venous sinus thrombosis
Q33889580The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms
Q55387461The effect of salusin-β on expression of pro- and anti-inflammatory cytokines in human umbilical vein endothelial cells (HUVECs).
Q36147794Thrombosis in systemic lupus erythematosus: a review article
Q37348644Tissue factor: A potent stimulator of Von Willebrand factor synthesis by human umbilical vein endothelial cells
Q51244914Treadmill exercise alleviates diabetic cardiomyopathy by suppressing plasminogen activator inhibitor expression and enhancing eNOS in streptozotocin-induced male diabetic rats.
Q38370197Venous thromboembolism in systemic autoimmune diseases: A narrative review with emphasis on primary systemic vasculitides
Q41519093Venous thromboembolism, interleukin-6 and survival outcomes in patients with advanced ovarian clear cell carcinoma.
Q90669258Young Women With Coronary Artery Disease Exhibit Higher Concentrations of Interleukin-6 at Baseline and in Response to Mental Stress
Q30581666β₂-Adrenergic agonists augment air pollution-induced IL-6 release and thrombosis

Search more.